Google

Overture Life, Inc. is a biotechnology company based in New York, established in 2017, that specializes in developing robotic solutions for in vitro fertilization (IVF) applications. The company focuses on automating the IVF process through innovative medical devices and embryo testing methodologies, which enhance the efficiency and success rates of fertility treatments. By optimizing resource use and lowering costs, Overture Life aims to make IVF more accessible to a broader audience. Its technology includes automated cryopreservation and embryo testing services, enabling fertility clinics to identify viable embryos prior to implantation, thereby improving patient outcomes and supporting individuals in their journey to parenthood.

Nym Health Inc., established in 2017 and headquartered in Boston, Massachusetts, specializes in medical coding technology for healthcare facilities. Its core product, Nym, is an autonomous coding solution that streamlines revenue cycle management. Nym reduces denials and operational expenses by directly billing and accurately assigning medical charge codes from patient charts, improving payment cycles and audit-readiness. It identifies relevant clinical aspects, assigns codes, and provides an audit trail explaining its coding decisions. With a research and development center in Tel Aviv-Yafo, Israel, Nym enables healthcare providers to enhance coding quality, lower costs, and focus more on patient care.

UJET, Inc. is a customer support software company that develops a cloud contact center platform tailored for modern customer experiences. Founded in 2015 and headquartered in San Francisco, with additional offices in New York and Seoul, UJET focuses on optimizing customer communications through voice and chat solutions. The platform integrates seamlessly with popular services like Salesforce, Zendesk, and Kustomer, enabling a unified approach to customer service that minimizes the need for customers to switch between different channels. By incorporating artificial intelligence, UJET enhances automation and boosts efficiency in customer interactions. Features such as online messaging, mobile capabilities, and a wait time messaging tool provide real-time updates, empowering agents to manage incoming calls effectively and resolve client issues promptly.

Cardurion Pharmaceuticals, LLC, established in 2017 and headquartered in Boston, Massachusetts, is a biotechnology company dedicated to developing innovative therapies for heart failure and other cardiovascular diseases. The company is advancing clinical programs that target PDE9 and CaMKII inhibition, utilizing its expertise in cardiovascular signaling pathways to address significant unmet patient needs.

Solstice facilitates shared solar energy solutions, aggregating consumer demand and connecting households with community solar projects. Founded in 2016, it aims to increase access to affordable renewable energy regardless of income or credit score.

If a technical career is what you seek, Benjamin Franklin Institute of Technology (BFIT) provides you with the education you need to pursue your professional goals. For over a century, BFIT has been one of Boston’s top career colleges. The institute has helped students reach their potential through technical education programs in the following types of fields: * Automotive Technology * Computer Technologies * Electronics Engineering Technology * Mechanical Engineering Technology * Medical Electronics Engineering Technology * Ophthalmic Assisting The Academic Success Center at BFIT ensures that students are given the resources and tools they need to excel in their academics and training. Some of the services offered through the center include: academic advising, special accommodations, tutoring, and more. College life at BFIT is filled with exciting experiences. From dorm life and council leadership to community service and intramural sports, the school encourages students to get involved in extracurricular activities. Applicants who are interested in admissions to the school must submit Accuplacer test results, an application, recommendation letters, and official transcripts for review. The school will waive its enrollment fee for any admissions applications submitted online. Merit and need-based financial aid exists in many forms at BFIT for those who qualify and are looking for tuition assistance.

Delphia Therapeutics, headquartered in Boston, USA, is a biotechnology company focused on cancer therapeutics. It operates a laboratory dedicated to studying cancer-driving pathways and developing treatments that target and over-activate specific cancer-linked cell signaling, ultimately leading to the death of tumor cells.

Cerevance develops novel therapeutics for neurological disorders such as Alzheimer's disease, Parkinson's disease, and other chronic neurodegenerative conditions. It uses a proprietary platform to profile specific brain cell types in human tissue samples, enabling the identification of promising targets for new treatments.

Oula Health, Inc. is a maternity care provider based in Brooklyn, New York, established in 2019. The company focuses on redesigning maternity care by integrating obstetrics and midwifery to create a personalized and evidence-based experience for expecting families. Oula operates clinics and offers home-based prenatal care services, aiming to set a new standard for pregnancy care that harmonizes modern medical practices with a compassionate approach. Through its innovative model, Oula Health seeks to enhance the overall maternity care experience for its clients.

Areteia Therapeutics is a biotechnology company focused on developing oral therapies for eosinophilic asthma to improve disease control. The company was spun out of Knopp and is advancing an oral drug designed to inhibit eosinophil maturation, aiming to reduce inflammation and alleviate symptoms of severe asthma. Phase 2 data from its program indicated the oral candidate lowers blood eosinophil counts, a marker associated with better lung function. By pursuing an oral, non-injectable treatment option, Areteia seeks to offer a convenient alternative to injectable therapies and broaden access for asthma patients. The company’s work centers on targeting eosinophil-related pathways to enhance asthma management and patient quality of life.

Oort is a decentralized data cloud platform focused on enhancing privacy and reducing costs by integrating global computing and storage resources. It offers enterprise-grade solutions tailored for generative AI and data-driven businesses, positioning itself as a pioneer in intelligent decentralized data cloud technology. The company holds US patents and has published academic research to support its innovations. With a headquarters in New York, Oort has established partnerships with over 40 organizations, including notable companies like DELL, Tencent Cloud, and Cardano, as well as collaborations with more than 20 prestigious universities in the United States, such as Harvard and MIT. The core team comprises professionals with experience from renowned institutions like Columbia University, Qualcomm, and JP Morgan, ensuring a strong foundation for its web3-native product development and geo-distributed computing capabilities.

ROME Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative therapies for cancer and autoimmune diseases. Founded in 2019, the company utilizes the repeatome, which encompasses extensive segments of genetic material previously regarded as "junk DNA," to identify new drug targets and advance multiple discovery programs. ROME Therapeutics has assembled a team of experts in oncology, immunology, virology, and machine learning to drive its research and development efforts, aiming to harness this uncharted area of biology for effective treatments. Through its work, ROME seeks to provide healthcare professionals with powerful new options for addressing complex medical challenges.

Nimbus Therapeutics, LLC is a biotechnology company based in Cambridge, Massachusetts, focused on discovering and developing innovative medicines for serious diseases, including metabolic disorders, cancer, and immune-inflammatory conditions. Founded in 2009, the company utilizes a computational technology-driven approach to advance a pipeline of novel small-molecule therapeutics. Nimbus Therapeutics specializes in designing allosteric inhibitors, notably targeting Acetyl-CoA Carboxylase for conditions such as non-alcoholic steatohepatitis and hepatocellular carcinoma. The company has established strategic partnerships with organizations like Charles River Laboratories and Celgene Corporation to enhance its drug development efforts. In March 2015, Nimbus Discovery rebranded itself as Nimbus Therapeutics to better reflect its transition into a clinical-stage enterprise.

Founded in 2016, Hugging Face is a New York-based company that aims to democratize good machine learning. It provides an open-source platform for collaborating on machine-learning projects, including models, datasets, and applications.

Chroma Medicine is a genomic medicine company founded in 2021 and based in Cambridge, Massachusetts, specializing in epigenetic editing. The company is pioneering a new class of genomic therapies aimed at revolutionizing the treatment of genetically driven diseases. By utilizing epigenetics, which is the natural mechanism for gene regulation, Chroma Medicine develops programmable epigenetic editors that target specific genes and modulate chromatin conformation. This innovative approach enables healthcare providers to achieve precise control of gene expression, offering a promising therapeutic option for conditions linked to genetic anomalies.

Founded in 2017, Superplastic is a Vermont-based company that creates character-based products and entertainment. It designs limited edition art toys, apparel, games, and animation, collaborating with renowned artists to bring unique characters to life.

Cerevance develops novel therapeutics for neurological disorders such as Alzheimer's disease, Parkinson's disease, and other chronic neurodegenerative conditions. It uses a proprietary platform to profile specific brain cell types in human tissue samples, enabling the identification of promising targets for new treatments.

Chronosphere, Inc. is a technology company that specializes in developing an open-source metrics data platform known as M3. Founded in 2019 and headquartered in New York, the company has additional offices in Seattle, Vilnius, and Warsaw. Chronosphere's platform provides comprehensive monitoring solutions for infrastructure, applications, and business metrics, enabling organizations to manage the complexities of cloud-native environments. By offering tools that help DevOps teams quickly identify and resolve issues across various layers of the technology stack, Chronosphere enhances operational reliability and supports data-driven decision-making. The platform is utilized by prominent brands to improve developer productivity, control costs, and enhance customer satisfaction.

Galileo is a technology company based in New York, founded in 2014, specializing in healthcare solutions. The company offers a mobile application and online communication platform that enables medical professionals to provide comprehensive clinical care directly from their phones. This includes synchronous and asynchronous telecommunications technologies for connecting providers with patients. Galileo's services cater to diverse patient populations, offering high-touch, data-driven, multi-specialty longitudinal care over the phone, at home, and in various settings. The company is recognized by regional and national health plans, employers, and Fortune 500 companies as a leading solution for improving population health.

Founded in 2018, Landis is a real estate technology company based in New York. It specializes in helping renters become homeowners by allowing customers to select their dream home, rent it initially, and purchase it anytime within the first twelve months. The company also assists customers in building credit and saving for a down payment, providing a transparent process for transitioning from renting to owning.

Phiar Technologies, a Boston-based company established in 2017, specializes in developing artificial intelligence solutions for vehicles. Its core product is an ultra-lightweight spatial AI engine that enables vehicles to perceive their surroundings in real-time using just a single camera and commodity mobile-grade processors. Phiar's initial focus is powering its Intelligent AR Navigation Platform, which provides drivers with safe and intuitive routing directions without requiring them to look away from the road.

Fractyl Health Inc. is a medical technology company dedicated to developing innovative solutions for the treatment of metabolic diseases, particularly type 2 diabetes and obesity. The company specializes in a minimally invasive procedure known as Revita DMR, or duodenal mucosal resurfacing therapy, which rejuvenates the lining of the duodenum through hydrothermal ablation. This approach aims to remove excessive layers of the duodenal mucosa that accumulate due to unhealthy diets, thereby addressing the root causes of metabolic disorders. Founded in 2010 and based in Lexington, Massachusetts, Fractyl Health seeks to redefine the treatment landscape from chronic management to durable, disease-modifying therapies, ultimately enhancing patient health and reducing the burden on healthcare systems.

Founded in 2018, Merlin Labs is based in Boston, Massachusetts. It specializes in developing autonomous flight technology for fixed-wing aircraft, using artificial intelligence and machine learning to enable goods transportation without human pilots.

Areteia Therapeutics is a biotechnology company focused on developing oral therapies for eosinophilic asthma to improve disease control. The company was spun out of Knopp and is advancing an oral drug designed to inhibit eosinophil maturation, aiming to reduce inflammation and alleviate symptoms of severe asthma. Phase 2 data from its program indicated the oral candidate lowers blood eosinophil counts, a marker associated with better lung function. By pursuing an oral, non-injectable treatment option, Areteia seeks to offer a convenient alternative to injectable therapies and broaden access for asthma patients. The company’s work centers on targeting eosinophil-related pathways to enhance asthma management and patient quality of life.

SingleStore is a data technology company that provides a distributed SQL database platform designed for real-time transactions and analytics. Its offerings include SingleStore DB, a distributed SQL database that can run on bare metal, in the cloud, or in hybrid deployments for operational analytics, and SingleStore Managed Service, a cloud database-as-a-service that provides analytics across a cloud of choice. The platform combines transactional and analytical processing in a single engine, supports real-time querying, multi-model data, and scalable ingestion, and aims to modernize data platforms, secure workloads, and support customer analytics across industries such as financial services, media and communications, energy and utilities, government, retail, and technology. Headquartered in San Francisco with additional offices, the company serves global enterprises by enabling real-time insights from data.

FYTO, Inc. is a company based in Cambridge, Massachusetts, founded in 2019, that specializes in the development of plant-based feed production systems. The firm focuses on creating nutrient-dense crops and innovative cultivation and harvesting systems designed to enhance agricultural quality and consistency. FYTO's offerings include a variety of agricultural products such as animal feed, fodder, plant-based proteins, nutritional supplements, and bio-fertilizers. By employing climate-friendly methodologies, the company aims to improve both the economic and environmental sustainability of agriculture, providing personalized solutions to farmers worldwide that promote ultra-high yields while minimizing resource requirements.

Sesame, Inc., operating as SesameCare, is a healthcare technology company founded in 2018 and based in New York, New York. The company has developed an innovative platform that enables users to book medical appointments and access healthcare services conveniently and affordably. By leveraging an AI-enabled marketplace, SesameCare eliminates the need for health insurance, fostering competition among healthcare providers based on quality, accessibility, and pricing. This approach allows the company to offer Americans high-quality medical care at significantly reduced costs. Additionally, Sesame is recognized as the official telehealth partner of Costco, further enhancing its reach and service offerings.

Nava is a health insurance brokerage based in New York, New York, dedicated to providing high-quality, affordable healthcare solutions to employers and their employees. The company offers a range of services that include healthcare tools, year-round employee advocacy, and continuous evaluation of healthcare plans. By leveraging these resources, Nava empowers clients to deliver essential benefits while simultaneously reducing overall plan costs. Its innovative approach aims to transform the employee benefits landscape through enhanced access and advocacy in healthcare.

Strella Biotechnology, founded in 2018 and headquartered in Philadelphia, Pennsylvania, focuses on enhancing the freshness of produce throughout the supply chain. The company specializes in designing and manufacturing sensors that detect ethylene gas, a key indicator of ripeness in fruits. By measuring ethylene production, Strella's technology helps optimize freshness and minimize spoilage. The company leverages its proprietary sensing technology to provide valuable data for improving supply chain management in the food industry.

Invetx, Inc. is a biotechnology company based in Boston, Massachusetts, specializing in the development of protein-based therapeutics for animal health care and veterinary medicine. The company employs a team of veterinary scientists and clinicians dedicated to the discovery and development of biotherapeutics for both pets and farm animals. Invetx aims to transform the animal health industry by leveraging biopharmaceutical technologies to improve health outcomes significantly. By combining deep expertise in veterinary science with innovative therapeutic solutions, Invetx seeks to advance the future of animal care, providing effective treatments that cater to the needs of various animal populations.

Celsius Therapeutics, Inc. is a biotechnology company focused on developing precision medicines for patients suffering from cancer and autoimmune diseases. Founded in 2018 and based in Cambridge, Massachusetts, the company employs a multidisciplinary approach, integrating the expertise of scientists, computational biologists, and clinicians. Celsius Therapeutics utilizes advanced techniques such as single-cell genomic analysis and machine learning to identify and develop innovative therapeutic solutions. By leveraging these cutting-edge technologies, the company aims to create life-changing medicines that address unmet medical needs.

LifeMine Therapeutics, Inc. is a biotechnology company focused on the genomic discovery of new drug modalities derived from eukaryotic microbes, specifically fungi. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in New York, it employs an integrated drug discovery platform that combines genomics, artificial intelligence, and synthetic biology. LifeMine’s Avatar-Rx platform utilizes high-throughput microbiology, data science, genome engineering, and automation technologies to identify novel gene-encoded molecules (GEMs) with specific biological functions. The company emphasizes chemoinformatic-assisted drug optimization and advanced chemical synthesis, enabling the progression of new product candidates into development. Founded by experts in the field, LifeMine Therapeutics aims to innovate medicine through its unique approach to leveraging the fungal biosphere.

Agolo is a technology company that builds an artificial intelligence driven platform to create real-time summaries from unstructured information. The platform leverages machine learning and natural language processing to convert messy data into a clean entity-graph based data store, powering enterprise use cases such as GenAI applications, large language models, RAG pipelines, business intelligence dashboards, support-site augmentation, and enterprise search. By providing concise, contextual summaries, the solution helps improve product quality, reduce support costs, and enable faster detection of emerging issues. The company, originally known as Ninoh, is based in New York.

Mandiant is a prominent provider of incident response and computer forensics solutions within the information security sector. Based in Alexandria, Virginia, the company operates additional offices in New York, Los Angeles, and San Francisco. Mandiant offers a range of products and professional services, including threat intelligence, automated response, and managed security, catering to a diverse clientele that includes Fortune 500 companies, financial institutions, government agencies, and law enforcement entities. With one of the largest teams dedicated to incident response and forensics, Mandiant is recognized for its expertise in mitigating cyber threats and enhancing organizational security measures. The company's consultants and engineers are highly qualified, holding advanced degrees and top government security clearances, and have authored numerous books on cybersecurity.

Founded in 2016, dbt Labs develops an open-source analytics engineering tool that empowers data analysts with SQL knowledge to build and share organizational knowledge through data modeling. Its platform facilitates collaborative deployment of analytics code, adhering to software engineering practices.

RightHand Robotics, Inc. is a manufacturer of robotic order-picking systems that streamline supply chain logistics for various industries, including e-commerce, food handling, and flexible manufacturing. Founded in 2015 and headquartered in Cambridge, Massachusetts, the company specializes in robotic solutions that automatically grasp a wide variety of items from bins and cases. Its flagship products include the ReFlex SF, which features a 3D-printed palm equipped with servos and compliant fingers, and the ReFlex TakkTile, a tactile sensor designed to enhance the robots' ability to handle items gently and correct errors. RightHand Robotics focuses on providing end-to-end solutions that simplify integration and adaptation to diverse customer workflows, ultimately reducing the costs associated with order fulfillment across sectors such as electronics, apparel, grocery, and pharmaceuticals.

Genesis Global Technology Limited specializes in developing custom software and solutions tailored for the capital markets. Founded in 2015 and headquartered in London, with an additional office in New York, the company provides a range of platforms designed to enhance trading and operational efficiency. Its offerings include an automated quoting system for managing requests for quotes, an order execution management system, and a trade allocation manager that facilitates various trading processes. Additionally, Genesis Global offers tools for data management and reconciliation, such as a short/long code manager and a matcher. The company is led by a team of industry veterans with substantial experience in trading technologies across multiple asset classes, aiming to deliver innovative solutions that align with the evolving needs of clients in the financial sector.

Scandit AG is a technology company specializing in barcode scanning software solutions and mobile computer vision. Founded in 2009 and headquartered in Zurich, Switzerland, with additional offices in the United States and Europe, Scandit develops applications that enable high-performance scanning on various smart devices, including smartphones, tablets, and wearables. Its offerings include the Barcode Scanner SDK, which transforms devices into enterprise-grade scanning tools, and the MatrixScan feature that enhances recognition processes for retail and logistics. Scandit's solutions are utilized across multiple industries, such as retail, healthcare, and manufacturing, to support applications like mobile shopping, inventory management, and asset tracking. The company's technology also incorporates augmented reality capabilities, providing real-time information overlays to improve user experience. Scandit aims to enhance operational efficiency and customer satisfaction for organizations, serving a diverse clientele that includes well-known brands.

Siemplify is a cybersecurity company that provides a holistic security operations platform designed to enhance the efficiency of security analysts. Founded in 2015 by experts from the Israeli Defense Forces, Siemplify offers a centralized workbench that enables security teams to investigate, analyze, and remediate threats more effectively. The platform uses advanced profiling algorithms to prioritize alerts, visualization techniques to map threats as interactive storylines, and graph analytics to integrate data from various systems. This approach reduces caseload and complexity for analysts, leading to faster response times and greater efficiency. Siemplify is headquartered in New York with additional offices in Tel Aviv.

Cockroach Labs, Inc. is a technology company that specializes in developing open-source database software, particularly known for its flagship product, CockroachDB. This cloud-native, distributed SQL database is designed to support the rapid scaling of applications while ensuring resilience against failures, including disk, machine, and datacenter outages. CockroachDB offers strong consistency and ACID transactions, along with an SQL API for efficient data management. The platform is utilized by a diverse range of customers, from small startups to Fortune 500 companies, across various industries such as finance, retail, and media. Founded in 2015, Cockroach Labs is headquartered in New York City, with an additional office in Cambridge, Massachusetts. The company focuses on enabling developers to build robust applications without compromising on performance or reliability.

Founded in 2014, Quartet Health operates a cloud-based platform facilitating communication between medical providers and behavioral health specialists for improved patient care. The platform works with health plans and systems to provide actionable insights on behavioral health conditions, enhancing patient outcomes.

Founded in 2017, mabl provides an intelligent test automation platform that integrates seamlessly into CI/CD pipelines. It enables software teams to create reliable, auto-healing tests, enhancing application quality and speeding up delivery.

Founded in 2017, Superplastic is a Vermont-based company that creates character-based products and entertainment. It designs limited edition art toys, apparel, games, and animation, collaborating with renowned artists to bring unique characters to life.

RightHand Robotics, Inc. is a manufacturer of robotic order-picking systems that streamline supply chain logistics for various industries, including e-commerce, food handling, and flexible manufacturing. Founded in 2015 and headquartered in Cambridge, Massachusetts, the company specializes in robotic solutions that automatically grasp a wide variety of items from bins and cases. Its flagship products include the ReFlex SF, which features a 3D-printed palm equipped with servos and compliant fingers, and the ReFlex TakkTile, a tactile sensor designed to enhance the robots' ability to handle items gently and correct errors. RightHand Robotics focuses on providing end-to-end solutions that simplify integration and adaptation to diverse customer workflows, ultimately reducing the costs associated with order fulfillment across sectors such as electronics, apparel, grocery, and pharmaceuticals.

ROME Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative therapies for cancer and autoimmune diseases. Founded in 2019, the company utilizes the repeatome, which encompasses extensive segments of genetic material previously regarded as "junk DNA," to identify new drug targets and advance multiple discovery programs. ROME Therapeutics has assembled a team of experts in oncology, immunology, virology, and machine learning to drive its research and development efforts, aiming to harness this uncharted area of biology for effective treatments. Through its work, ROME seeks to provide healthcare professionals with powerful new options for addressing complex medical challenges.

SingleStore is a data technology company that provides a distributed SQL database platform designed for real-time transactions and analytics. Its offerings include SingleStore DB, a distributed SQL database that can run on bare metal, in the cloud, or in hybrid deployments for operational analytics, and SingleStore Managed Service, a cloud database-as-a-service that provides analytics across a cloud of choice. The platform combines transactional and analytical processing in a single engine, supports real-time querying, multi-model data, and scalable ingestion, and aims to modernize data platforms, secure workloads, and support customer analytics across industries such as financial services, media and communications, energy and utilities, government, retail, and technology. Headquartered in San Francisco with additional offices, the company serves global enterprises by enabling real-time insights from data.

Nym Health Inc., established in 2017 and headquartered in Boston, Massachusetts, specializes in medical coding technology for healthcare facilities. Its core product, Nym, is an autonomous coding solution that streamlines revenue cycle management. Nym reduces denials and operational expenses by directly billing and accurately assigning medical charge codes from patient charts, improving payment cycles and audit-readiness. It identifies relevant clinical aspects, assigns codes, and provides an audit trail explaining its coding decisions. With a research and development center in Tel Aviv-Yafo, Israel, Nym enables healthcare providers to enhance coding quality, lower costs, and focus more on patient care.

Founded in 2018 by Joshua Abram, Alan Murray, and Dr. Jeffrey Port, TMRW Life Sciences is a pioneering life sciences company specializing in fertility technology. It offers an automated cryo-management platform for eggs and embryos, providing a complete digital chain of custody integrated with robotic storage and monitoring solutions. This innovative approach significantly reduces human error compared to traditional manual methods in IVF procedures.

Ribon Therapeutics, Inc. is a biotechnology company founded in 2015 and headquartered in Lexington, Massachusetts. The company focuses on developing novel therapeutics that target monoPARP proteins, which are critical regulators of cancer cell survival mechanisms. By leveraging insights from its scientific founders, Ribon is establishing a proprietary drug discovery platform aimed at investigating the molecular actions and biological functions of a specific subset of the PARP protein family. This platform enables Ribon to create a pipeline of innovative small molecule inhibitors designed to disrupt the fundamental survival capabilities of cancer cells under stress. In addition to cancer treatment, the company's research may have implications for addressing other diseases. Ribon is supported by notable life science investors, which enhances its capacity to advance its therapeutic developments.

Founded in 2018, Merlin Labs is based in Boston, Massachusetts. It specializes in developing autonomous flight technology for fixed-wing aircraft, using artificial intelligence and machine learning to enable goods transportation without human pilots.

Bowery Farming Inc. is a modern agricultural company based in New York, specializing in post-organic produce. Founded in 2014, the company focuses on growing a variety of greens, including baby kale, lettuce, arugula, and basil, using innovative indoor farming techniques. By leveraging advanced technology, such as its proprietary BoweryOS software, Bowery Farming creates optimal conditions for plant growth, allowing it to operate without pesticides and using significantly less water compared to traditional farming methods. This technology enables the company to be over 100 times more productive on the same land footprint. Bowery's products are distributed through grocery stores and featured in the menus of renowned restaurants, emphasizing the company's commitment to providing fresh, sustainable produce to consumers.

Overture Life, Inc. is a biotechnology company based in New York, established in 2017, that specializes in developing robotic solutions for in vitro fertilization (IVF) applications. The company focuses on automating the IVF process through innovative medical devices and embryo testing methodologies, which enhance the efficiency and success rates of fertility treatments. By optimizing resource use and lowering costs, Overture Life aims to make IVF more accessible to a broader audience. Its technology includes automated cryopreservation and embryo testing services, enabling fertility clinics to identify viable embryos prior to implantation, thereby improving patient outcomes and supporting individuals in their journey to parenthood.

Founded in 2018, Dyno Therapeutics specializes in developing adeno-associated virus (AAV) vectors for in vivo gene therapy delivery. The company's proprietary platform combines DNA synthesis of AAV capsids with sequencing and machine learning to create novel vectors tailored for safe, efficient, and targeted therapeutic solutions.

Affinia Therapeutics develops adeno-associated virus (AAV) gene therapies for muscular and central nervous system diseases. The company uses an AAV vector design platform built on synthetic and systems biology, high-throughput screening, and tissue- and single-cell-resolution analyses to create vectors with improved properties. It leverages sequencing, artificial intelligence, and structural modeling to enable rational design of therapies. Headquartered in Waltham, Massachusetts, Affinia Therapeutics was founded in 2019 and targets diseases with significant unmet needs in muscle and CNS.

Treeline Biosciences is a biotechnology company focused on developing precision medicines for cancer and other serious diseases. Founded in 2021 and based in Stamford, Connecticut, the company uses a platform that integrates pathophysiology, genomics, and pattern recognition to identify therapeutic approaches that address unmet patient needs.

Founded in 2019, Tend is a modern dental practice committed to redefining oral healthcare. With over 650 team members across 25 locations in six major U.S. cities, Tend offers personalized, hassle-free dental services in inviting spaces, focusing on patient happiness and comfort.

SecurityScorecard, Inc., founded in 2013 by Dr. Alex Yampolskiy and Sam Kassoumeh, is a leading provider of cybersecurity ratings and continuous monitoring services. The company's platform assesses the cybersecurity strength of third-party vendors and businesses, offering solutions like ThreatMarket, a cloud-based vulnerability search engine, and Score Planner for remediation paths. SecurityScorecard serves Fortune 1000 organizations worldwide, providing tools for vendor risk management, board reporting, and cyber insurance underwriting. Its patented technology rates over a million companies continuously, enabling organizations to identify and mitigate cybersecurity risks across their digital footprint. The company is based in New York, New York.

Genesis Global Technology Limited specializes in developing custom software and solutions tailored for the capital markets. Founded in 2015 and headquartered in London, with an additional office in New York, the company provides a range of platforms designed to enhance trading and operational efficiency. Its offerings include an automated quoting system for managing requests for quotes, an order execution management system, and a trade allocation manager that facilitates various trading processes. Additionally, Genesis Global offers tools for data management and reconciliation, such as a short/long code manager and a matcher. The company is led by a team of industry veterans with substantial experience in trading technologies across multiple asset classes, aiming to deliver innovative solutions that align with the evolving needs of clients in the financial sector.

Snyk Ltd., established in 2015, specializes in a Software as a Service (SaaS) platform that enhances application security. It focuses on identifying, rectifying, and monitoring known vulnerabilities across critical components of modern applications, including code, open-source libraries, containers, and infrastructure as code. Snyk's offerings, such as Snyk Code (static application security testing), container vulnerability management, and application security management, integrate seamlessly with developers' workflows, improving security posture, productivity, and collaboration. With over 1,200 global customers, including industry leaders like Google and Salesforce, Snyk is recognized for its developer-first approach and strategic partnerships.

TScan Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and developing T cell receptor (TCR) engineered T cell therapies for cancer treatment. Its primary focus is on liquid tumors, with lead therapy candidates TSC-100 and TSC-101 aimed at addressing hematologic malignancies by targeting residual leukemia and preventing relapse following hematopoietic stem cell transplantation. In addition to its liquid tumor programs, TScan is advancing multiplexed TCR-T therapy candidates to tackle various solid tumors. The company employs a unique platform that identifies previously uncharacterized shared T cell antigens and assesses off-target TCR interactions, which supports the creation of TCR-T therapies with reduced off-target effects. Founded in 2018 and headquartered in Waltham, Massachusetts, TScan Therapeutics aims to transform cancer treatment through innovative T cell therapies.

Verve Therapeutics is a biotechnology company developing genetic medicines for cardiovascular disease, aiming to transform treatment from chronic management to single-course gene editing therapies. It leverages human genetics analysis and gene-editing technology, with expertise in cardiovascular medicine, human genetics, gene editing, delivery technologies, drug development, and commercialization.

Cockroach Labs, Inc. is a technology company that specializes in developing open-source database software, particularly known for its flagship product, CockroachDB. This cloud-native, distributed SQL database is designed to support the rapid scaling of applications while ensuring resilience against failures, including disk, machine, and datacenter outages. CockroachDB offers strong consistency and ACID transactions, along with an SQL API for efficient data management. The platform is utilized by a diverse range of customers, from small startups to Fortune 500 companies, across various industries such as finance, retail, and media. Founded in 2015, Cockroach Labs is headquartered in New York City, with an additional office in Cambridge, Massachusetts. The company focuses on enabling developers to build robust applications without compromising on performance or reliability.

EQRx, Inc. is a biotechnology company based in Cambridge, Massachusetts, established in 2019. The company focuses on re-engineering the drug discovery and delivery process to provide a market-based solution to the escalating costs of medications. EQRx aims to enhance the efficiency and affordability of high-quality, patent-protected medicines by collaborating with various stakeholders across the healthcare system and leveraging advancements in science and technology. The company has developed a robust pipeline with over ten programs, including clinical and preclinical projects targeting oncology and immune-inflammatory conditions, featuring compounds such as Aumolertinib, Lerociclib, Sugemalimab, and Nofazinlimab.

LifeMine Therapeutics, Inc. is a biotechnology company focused on the genomic discovery of new drug modalities derived from eukaryotic microbes, specifically fungi. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in New York, it employs an integrated drug discovery platform that combines genomics, artificial intelligence, and synthetic biology. LifeMine’s Avatar-Rx platform utilizes high-throughput microbiology, data science, genome engineering, and automation technologies to identify novel gene-encoded molecules (GEMs) with specific biological functions. The company emphasizes chemoinformatic-assisted drug optimization and advanced chemical synthesis, enabling the progression of new product candidates into development. Founded by experts in the field, LifeMine Therapeutics aims to innovate medicine through its unique approach to leveraging the fungal biosphere.

SingleStore is a data technology company that provides a distributed SQL database platform designed for real-time transactions and analytics. Its offerings include SingleStore DB, a distributed SQL database that can run on bare metal, in the cloud, or in hybrid deployments for operational analytics, and SingleStore Managed Service, a cloud database-as-a-service that provides analytics across a cloud of choice. The platform combines transactional and analytical processing in a single engine, supports real-time querying, multi-model data, and scalable ingestion, and aims to modernize data platforms, secure workloads, and support customer analytics across industries such as financial services, media and communications, energy and utilities, government, retail, and technology. Headquartered in San Francisco with additional offices, the company serves global enterprises by enabling real-time insights from data.

Founded in 2008, Hodinkee is a leading online platform dedicated to the world of watches. It offers comprehensive reviews, news, and historical insights on timepieces, along with an e-boutique selling vintage watches, straps, menswear accessories, and other watch-related products. Hodinkee also operates pop-up shops in the United States.

Decibel Therapeutics, Inc. is a clinical-stage biotechnology company focused on discovering and developing innovative therapies aimed at protecting, repairing, and restoring hearing. The company addresses various hearing disorders, including those related to pediatric cancers, cystic fibrosis, noise exposure, age-related and genetic hearing loss, as well as conditions characterized by persistent tinnitus. Decibel Therapeutics employs a multifaceted approach that includes drug delivery to the inner ear, advanced imaging techniques, and pharmacokinetic and pharmacodynamic modeling. The company leverages its expertise in inner ear biology, single-cell genomics, and bioinformatics to develop effective treatments for hearing loss and related disorders. Established in 2013 and headquartered in Boston, Massachusetts, Decibel Therapeutics was originally known as Hearing, Inc. before rebranding in 2014.

Founded in 2017, Superplastic is a Vermont-based company that creates character-based products and entertainment. It designs limited edition art toys, apparel, games, and animation, collaborating with renowned artists to bring unique characters to life.

Nym Health Inc., established in 2017 and headquartered in Boston, Massachusetts, specializes in medical coding technology for healthcare facilities. Its core product, Nym, is an autonomous coding solution that streamlines revenue cycle management. Nym reduces denials and operational expenses by directly billing and accurately assigning medical charge codes from patient charts, improving payment cycles and audit-readiness. It identifies relevant clinical aspects, assigns codes, and provides an audit trail explaining its coding decisions. With a research and development center in Tel Aviv-Yafo, Israel, Nym enables healthcare providers to enhance coding quality, lower costs, and focus more on patient care.

Founded in 2019, Tend is a modern dental practice committed to redefining oral healthcare. With over 650 team members across 25 locations in six major U.S. cities, Tend offers personalized, hassle-free dental services in inviting spaces, focusing on patient happiness and comfort.

Our first app, HAGS: Yearbook Signatures, let let tens of thousands of students sign their yearbooks through Snapchat. HAGS will be relaunching as an entirely new space for high school students to interact with their class. Based in New York.

UJET, Inc. is a customer support software company that develops a cloud contact center platform tailored for modern customer experiences. Founded in 2015 and headquartered in San Francisco, with additional offices in New York and Seoul, UJET focuses on optimizing customer communications through voice and chat solutions. The platform integrates seamlessly with popular services like Salesforce, Zendesk, and Kustomer, enabling a unified approach to customer service that minimizes the need for customers to switch between different channels. By incorporating artificial intelligence, UJET enhances automation and boosts efficiency in customer interactions. Features such as online messaging, mobile capabilities, and a wait time messaging tool provide real-time updates, empowering agents to manage incoming calls effectively and resolve client issues promptly.

Founded in 2018, Sana Biotechnology focuses on creating and delivering engineered cells as medicine for patients. The company aims to reprogram cells in the body or replace damaged ones to treat a broad range of diseases, with a pipeline including SC291, SC262, SC255, UP421, and other candidates across therapeutic areas like oncology, diabetes, autoimmune disorders, and CNS.

Verve Therapeutics is a biotechnology company developing genetic medicines for cardiovascular disease, aiming to transform treatment from chronic management to single-course gene editing therapies. It leverages human genetics analysis and gene-editing technology, with expertise in cardiovascular medicine, human genetics, gene editing, delivery technologies, drug development, and commercialization.

PatientPing, Inc. is a health technology company that has developed a national care coordination network aimed at enhancing communication among healthcare providers. Founded in 2013 and headquartered in Boston, Massachusetts, the company offers real-time notifications and care guidelines to various healthcare professionals, including physicians, nurses, case managers, and care coordinators. This network spans hospitals, emergency departments, accountable care organizations, physician practices, skilled nursing facilities, home health agencies, and payers. PatientPing's platform includes a tool called Spotlights, which leverages real-time data to analyze utilization and performance trends in patient care. By improving information sharing among care teams, PatientPing facilitates higher quality, cost-effective care, ultimately aiming to enhance patient outcomes and experiences. The company also maintains a strategic partnership with MedAllies, Inc. and operates as a subsidiary of SVB Leerink Holdings LLC.

Scandit AG is a technology company specializing in barcode scanning software solutions and mobile computer vision. Founded in 2009 and headquartered in Zurich, Switzerland, with additional offices in the United States and Europe, Scandit develops applications that enable high-performance scanning on various smart devices, including smartphones, tablets, and wearables. Its offerings include the Barcode Scanner SDK, which transforms devices into enterprise-grade scanning tools, and the MatrixScan feature that enhances recognition processes for retail and logistics. Scandit's solutions are utilized across multiple industries, such as retail, healthcare, and manufacturing, to support applications like mobile shopping, inventory management, and asset tracking. The company's technology also incorporates augmented reality capabilities, providing real-time information overlays to improve user experience. Scandit aims to enhance operational efficiency and customer satisfaction for organizations, serving a diverse clientele that includes well-known brands.

Founded in 2016, Owkin is a French-American startup that uses artificial intelligence to enhance medical research. It develops machine learning tools to understand complex biology, identify new treatments, de-risk clinical trials, and develop diagnostics. Owkin's focus is improving drug discovery processes and patient outcomes.

Cockroach Labs, Inc. is a technology company that specializes in developing open-source database software, particularly known for its flagship product, CockroachDB. This cloud-native, distributed SQL database is designed to support the rapid scaling of applications while ensuring resilience against failures, including disk, machine, and datacenter outages. CockroachDB offers strong consistency and ACID transactions, along with an SQL API for efficient data management. The platform is utilized by a diverse range of customers, from small startups to Fortune 500 companies, across various industries such as finance, retail, and media. Founded in 2015, Cockroach Labs is headquartered in New York City, with an additional office in Cambridge, Massachusetts. The company focuses on enabling developers to build robust applications without compromising on performance or reliability.

ROME Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative therapies for cancer and autoimmune diseases. Founded in 2019, the company utilizes the repeatome, which encompasses extensive segments of genetic material previously regarded as "junk DNA," to identify new drug targets and advance multiple discovery programs. ROME Therapeutics has assembled a team of experts in oncology, immunology, virology, and machine learning to drive its research and development efforts, aiming to harness this uncharted area of biology for effective treatments. Through its work, ROME seeks to provide healthcare professionals with powerful new options for addressing complex medical challenges.

Cerevance develops novel therapeutics for neurological disorders such as Alzheimer's disease, Parkinson's disease, and other chronic neurodegenerative conditions. It uses a proprietary platform to profile specific brain cell types in human tissue samples, enabling the identification of promising targets for new treatments.

EQRx, Inc. is a biotechnology company based in Cambridge, Massachusetts, established in 2019. The company focuses on re-engineering the drug discovery and delivery process to provide a market-based solution to the escalating costs of medications. EQRx aims to enhance the efficiency and affordability of high-quality, patent-protected medicines by collaborating with various stakeholders across the healthcare system and leveraging advancements in science and technology. The company has developed a robust pipeline with over ten programs, including clinical and preclinical projects targeting oncology and immune-inflammatory conditions, featuring compounds such as Aumolertinib, Lerociclib, Sugemalimab, and Nofazinlimab.

TScan Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and developing T cell receptor (TCR) engineered T cell therapies for cancer treatment. Its primary focus is on liquid tumors, with lead therapy candidates TSC-100 and TSC-101 aimed at addressing hematologic malignancies by targeting residual leukemia and preventing relapse following hematopoietic stem cell transplantation. In addition to its liquid tumor programs, TScan is advancing multiplexed TCR-T therapy candidates to tackle various solid tumors. The company employs a unique platform that identifies previously uncharacterized shared T cell antigens and assesses off-target TCR interactions, which supports the creation of TCR-T therapies with reduced off-target effects. Founded in 2018 and headquartered in Waltham, Massachusetts, TScan Therapeutics aims to transform cancer treatment through innovative T cell therapies.

Kitchen United, Inc. is a food production company based in Pasadena, California, founded in 2017. It specializes in offering shared commercial kitchen spaces designed for restaurants, catering services, pop-ups, mobile food vendors, and startups. By providing turnkey solutions and business intelligence resources, Kitchen United enables food service providers to expand their operations with minimal financial risk. The company facilitates food production for pick-up and delivery, catering to the growing demand for convenient dining options. Kitchen United operates multiple locations across major cities, including Austin, Chicago, Los Angeles, San Francisco, New York City, and Scottsdale, thereby supporting a diverse range of culinary entrepreneurs in realizing their business potential.

Snyk Ltd., established in 2015, specializes in a Software as a Service (SaaS) platform that enhances application security. It focuses on identifying, rectifying, and monitoring known vulnerabilities across critical components of modern applications, including code, open-source libraries, containers, and infrastructure as code. Snyk's offerings, such as Snyk Code (static application security testing), container vulnerability management, and application security management, integrate seamlessly with developers' workflows, improving security posture, productivity, and collaboration. With over 1,200 global customers, including industry leaders like Google and Salesforce, Snyk is recognized for its developer-first approach and strategic partnerships.

Socratic, Inc. is an education technology company that specializes in developing a homework assistance application for students. Founded in 2013 and based in New York, the company utilizes artificial intelligence to provide users with answers, detailed explanations, and curated educational content across a variety of subjects, including math, science, history, English, and economics. The app allows students to take photos of their homework questions, making it accessible and user-friendly. It features graphs, explainers, and links to instructional videos from platforms such as Khan Academy, enhancing the learning experience. Socratic is available for free on both iPhone and Android devices, focusing primarily on high school curriculum support. The company, formerly known as Vespr, Inc., rebranded to Socratic, Inc. in May 2015.

Cockroach Labs, Inc. is a technology company that specializes in developing open-source database software, particularly known for its flagship product, CockroachDB. This cloud-native, distributed SQL database is designed to support the rapid scaling of applications while ensuring resilience against failures, including disk, machine, and datacenter outages. CockroachDB offers strong consistency and ACID transactions, along with an SQL API for efficient data management. The platform is utilized by a diverse range of customers, from small startups to Fortune 500 companies, across various industries such as finance, retail, and media. Founded in 2015, Cockroach Labs is headquartered in New York City, with an additional office in Cambridge, Massachusetts. The company focuses on enabling developers to build robust applications without compromising on performance or reliability.

Agolo is a technology company that builds an artificial intelligence driven platform to create real-time summaries from unstructured information. The platform leverages machine learning and natural language processing to convert messy data into a clean entity-graph based data store, powering enterprise use cases such as GenAI applications, large language models, RAG pipelines, business intelligence dashboards, support-site augmentation, and enterprise search. By providing concise, contextual summaries, the solution helps improve product quality, reduce support costs, and enable faster detection of emerging issues. The company, originally known as Ninoh, is based in New York.

TScan Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and developing T cell receptor (TCR) engineered T cell therapies for cancer treatment. Its primary focus is on liquid tumors, with lead therapy candidates TSC-100 and TSC-101 aimed at addressing hematologic malignancies by targeting residual leukemia and preventing relapse following hematopoietic stem cell transplantation. In addition to its liquid tumor programs, TScan is advancing multiplexed TCR-T therapy candidates to tackle various solid tumors. The company employs a unique platform that identifies previously uncharacterized shared T cell antigens and assesses off-target TCR interactions, which supports the creation of TCR-T therapies with reduced off-target effects. Founded in 2018 and headquartered in Waltham, Massachusetts, TScan Therapeutics aims to transform cancer treatment through innovative T cell therapies.

Founded in 2014, Quartet Health operates a cloud-based platform facilitating communication between medical providers and behavioral health specialists for improved patient care. The platform works with health plans and systems to provide actionable insights on behavioral health conditions, enhancing patient outcomes.

Yellowbrick Learning is an online platform that designs learning experiences to help individuals discover and pursue career paths in creative industries such as fashion, beauty, music, sports, and media. It aims to empower the next generation to upskill and advance their careers in the creative arts, media, and entertainment by collaborating with industry leaders to develop experiences and assignments that build relevant skills and provide industry insights. The company partners with leading universities, brands, and employers to align learners' talents and interests with practical opportunities, enabling students to explore and pursue career paths with confidence.

Iridescent's mission is to create and deliver powerful science, engineering, and technology education to help underprivileged children develop curiosity, creativity, and persistence. Iridescent runs in-person programs at our science studios in south LA and the south Bronx, including our Family Science programs, which connect engineering students with under-served students and their families through hands-on engineering design challenges. All of these challenges are also available online, through our online learning platform The Curiosity Machine, where students are virtually mentored by STEM professionals with every design they submit. Iridescent also runs the Technovation Challenge, the largest global technology entrepreneurship program for young women.

Verve Therapeutics is a biotechnology company developing genetic medicines for cardiovascular disease, aiming to transform treatment from chronic management to single-course gene editing therapies. It leverages human genetics analysis and gene-editing technology, with expertise in cardiovascular medicine, human genetics, gene editing, delivery technologies, drug development, and commercialization.

Arrakis Therapeutics, Inc. is a biopharmaceutical company based in Waltham, Massachusetts, that specializes in drug discovery focused on ribonucleic acid (RNA) targets. Established in 2015, the company utilizes a proprietary platform that combines advanced RNA bioinformatics, structural tools, and chemical libraries to identify new RNA targets and develop RNA-targeted small molecules (rSMs). This innovative approach aims to address various diseases, including cancer, neurological disorders, and rare genetic conditions. Arrakis also offers SHAPEware, a software tool designed to analyze and predict RNA secondary structures and potential ligand-binding sites, further enhancing its drug development capabilities. Through its comprehensive pipeline, Arrakis Therapeutics seeks to improve treatment options and outcomes for patients across multiple therapeutic areas.

Lemonade, Inc. is an innovative insurance company that provides a range of insurance products in the United States and Europe, including homeowners, renters, and landlord insurance. Founded in 2015 and headquartered in New York, the company utilizes artificial intelligence and behavioral economics to streamline the insurance process, eliminating traditional brokers and paperwork. By employing advanced technology, Lemonade offers instant service and sets competitive rates for its policies. The company also acts as an agent for other insurance providers, further expanding its offerings. With a commitment to social good, Lemonade aims to transform the insurance industry by prioritizing transparency and efficiency.

Lola Travel Company, Inc. specializes in corporate travel management through its AI-driven platform, Lola.com. Established in 2015 and headquartered in Boston, Massachusetts, the company simplifies the travel booking process for businesses by offering an intuitive tool for flight and hotel reservations. Lola.com allows users to manage itineraries via a mobile application, providing individual travel profiles, digital travel receipts, and budget tracking services. The platform also supports employee-friendly travel policies, efficient spend reporting for managers, and features that enable team destination sharing and loyalty point accumulation. With 24/7 agent assistance and capabilities for executive assistants to book travel on behalf of others, Lola.com caters to the needs of both employers and business travelers, streamlining the overall travel experience.

Founded in 2016, Owkin is a French-American startup that uses artificial intelligence to enhance medical research. It develops machine learning tools to understand complex biology, identify new treatments, de-risk clinical trials, and develop diagnostics. Owkin's focus is improving drug discovery processes and patient outcomes.

Beam Therapeutics is a biotechnology company developing precision genetic medicines using its proprietary base editing technology. Its focus includes therapies for hematological and genetic diseases, with ongoing programs targeting sickle cell disease, alpha-1 antitrypsin deficiency, and other serious conditions.

CTRL-Labs develops neural interface technologies that enable humans to interact with machines using natural movements and thoughts. Their flagship product, CTRL-kit, is a wireless, non-invasive electromyography device that translates neural signals into control for applications in XR, robotics, productivity, and clinical research.

2nd Address, Inc. is an online marketplace that specializes in booking and listing furnished apartments, homes, and condominiums primarily for short-term travel. Founded in 2014 and headquartered in San Francisco, the company offers a seamless experience for tenants and landlords, providing options for short-term, long-term, and month-to-month leases in major urban markets across the United States, including Washington, D.C., California cities such as San Francisco and Los Angeles, as well as in New York, Boston, Seattle, Alexandria, and Chicago. By catering to both individual travelers and corporate clients, including notable companies such as Google and Facebook, 2nd Address simplifies the rental process, making it easier for guests to find and manage their temporary homes. Formerly known as HomeSuite, Inc., the company rebranded in November 2017, reflecting its commitment to enhancing the experience of business travel through diverse and premium housing options.

Managed by Q Inc. is a workplace management platform headquartered in New York, New York, that streamlines the operation of office environments. Founded in 2013, the company provides a comprehensive range of services, including on-demand cleaning, maintenance, IT support, and security. Its technology platform serves as an all-in-one solution for businesses, connecting them to essential services such as supply replenishment, task management, and project management, which encompasses pre-lease planning, vendor management, office design, and renovations. By facilitating seamless office operations, Managed by Q aims to save time and resources for businesses while promoting economic empowerment through job creation and support for small businesses. The company operates in key markets, including New York, Los Angeles, Chicago, and San Francisco.